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Off-pump coronary artery bypass grafting (OPCAB) with-
out cardiopulmonary bypass has evolved during the past 2
decades and has gained popularity in many centers. Despite
favorable evidence from both prospective randomized trials
and large observational studies, however, the adoption of
OPCAB has been variable both worldwide and in the United
Kingdom, where it has plateaued at approximately 17%.1
Moreover, recent studies suggest that OPCAB may be asso-
ciated with adverse outcomes. The goals of this editorial are
to evaluate critically the current status of OPCAB in the light
of recent evidence and to suggest its future direction.
OFF-PUMP VERSUS ON-PUMP: IMPLICATIONS
OF THE EVIDENCE
The routine application of OPCAB is as safe as coronary
artery bypass grafting with cardiopulmonary bypass
(ONCAB). Meta-analyses of randomized controlled trials
in low-risk patients demonstrate similar outcomes for both
interventions in terms of mortality, myocardial infarction,
and need for repeat revascularization at 1 and 2 years.2,3
They also demonstrate that OPCAB is associated with
reductions in the risks for stroke (50%), atrial fibrillation
(30%), wound infection (48%), and acute kidney injury
(70%).3-5 OPCAB also reduces transfusion and inotrope
requirements, ventilation time, intensive care unit and
hospital stays, and in-hospital and 1-year direct costs.6,7
Our group has recently reported long term follow-up at 6
to 8 years among survivors of the BHACS-1 and BHACS-
2 trials.8 We found no difference in the likelihoods of graft
occlusion (odds ratio [OR], 1.00; 95% confidence interval
[CI], 0.55–1.81), death (hazard ratio [HR], 1.24; 95% CI,
0.72–2.15), major adverse cardiac-related events (HR,
0.84; 95% CI, 0.58–1.24) or health-related quality of life
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The Journal of Thoracic and CaThe recent ROOBY trial, however, a prospective, multi-
center trial with 2000 patients randomly assigned to undergo
OPCAB or ONCAB during a 6-year period, reported a 33%
increase in the risk of the primary long-term composite end
point of death from any cause, nonfatal myocardial infarc-
tion, or repeat revascularization within 1 year for patients
undergoing OPCAB (relative risk, 1.33; 95% CI, 1.01–
1.76; P¼ .04; number needed to cause 1 harmful event, 71).9
This study, however, had several major limitations. More
than 70% of eligible patients (scheduled for urgent or elec-
tive coronary artery bypass grafting) were excluded because
of clinical reservations of the surgical team or small target
vessels. This suggests inexperience of surgeons in the trial,
who were required to have performed just 20 OPCAB pro-
cedures to participate. Conversion to ONCAB, which is
known to increase morbidity and mortality,10,11 occurred
in more than 12% of cases, much greater than the 1% to
3% reported by centers specializing in OPCAB.11,12 In the
OPCAB group, more than 50% of patients received red
blood cell transfusions, which contrasts with the 30% in
previous randomized trials.7 Finally, only a small minority
of the studied population were high-risk patients, a group
more likely to benefit from OPCAB.
Although data from randomized trials provide the most ac-
curate evidence, they are underpowered to demonstrate a dif-
ference in hard end points. Several large propensity-matched
retrospective series and meta-analyses from centers proficient
in OPCAB have provided compelling evidence in favor of
the technique. A retrospective analysis of 49,830 patients
from the New York state registry reported lower 30-day mor-
tality and incidences of postoperative stroke and respiratory
failure for risk-adjusted isolated OPCAB versus ONCAB
surgery.13 Three-year follow-up revealed that patients who
had undergone OPCAB did have a higher rate of repeat re-
vascularization; however, survival was equivalent between
the groups.13 A similar intention-to-treat analysis of 42,477
patients from the Society of Thoracic Surgeons National
Adult Cardiac Surgery database showed reductions in risk-
adjusted mortality, stroke, perioperative myocardial infarc-
tion, renal failure, mediastinitis, need for reoperation, atrial
fibrillation, and prolonged ventilation for patients in the OP-
CAB group versus the ONCAB group.14 A meta-analysis of
22 risk-adjusted (logistic regression or propensity-score)
observational studies (n ¼ 293,617) showed OPCAB to be
associated with reduced 30-day mortality (OR, 0.72; 95%
CI, 0.66–0.78), stroke (OR, 0.62; 95% CI, 0.55–0.69), myo-
cardial infarction (OR, 0.66; 95% CI, 0.50–0.88), and atrial
fibrillation (OR, 0.78; 95% CI, 0.74–0.82).15 At 1 to 2 years,rdiovascular Surgery c Volume 140, Number 5 951
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but also increased repeat revascularization (OR, 1.35; 95%
CI, 0.76–2.39). These reports from large-volume centers
suggest that OPCAB is a specialized technique requiring ded-
ication, infrastructure, and expertise to achieve proficiency
and good results.
This in turn raises 2 important questions that relate to the
future direction of OPCAB. First, how should OPCAB,
a specialized technique, be safely introduced into routine
clinical practice? Second, what group of patients will benefit
most from OPCAB?
A SPECIALIZED TECHNIQUE FOR EXPERTS?
The adoption of OPCAB has been highly variable. The
reasons for this include the lack of established training pro-
grams, the perception that success with the technique is lim-
ited to more proficient surgeons, and a fear of deleterious
patient outcomes, especially during the learning curve.16
In the largest review of the incorporation of OPCAB into
a surgical practice (12,540 patients undergoing coronary ar-
tery bypass grafting, including 1915 OPCAB procedures),
Mack and colleagues12 reported an increase in OPCAB
from 1.2% of cases in 1995 to 34.1% of cases in 2000 (in-
dividual surgeon adoption rates ranged from 1% to 96% by
2000). Initially, OPCAB case selection considered only
elective cases requiring a limited number of grafts (2 or 3)
to the anterior surface of the heart, with patients in an unsta-
ble condition, those undergoing reoperation, and those re-
quiring multiple bypasses on the lateral surface generally
considered unsuitable. As surgeon experience increased
along with developments in stabilizer technology, however,
all patients were considered for OPCAB. The OPCAB to
ONCAB conversion rate in this series was 2.9%. The in-
creased use of OPCAB was associated with a reduction in
hospital mortality from 4% to 3.2% and a reduction in pro-
cedural morbidity.
In our unit, between 1997 and 2001, the proportion of OP-
CAB cases increased from 8% to 68%without any increase
in procedural morbidity. This change was accompanied by
gradual increases in the complexity of cases, number of dis-
tal anastomoses, use of multiple arterial conduits, and lateral
wall revascularization.17,18
Key elements to the adoption of OPCAB are appropriate
patient selection, individualized grafting strategy, peer-to-
peer training of the entire team, and graded clinical experi-
ence (preoperative planning, adequate exposure, proximal
anastomoses to the aorta, distal anastomoses initially to an-
terior wall vessels, followed by inferior wall vessels and then
lateral wall vessels).19 In our experience, the surgeon’s
learning curve is around 50 to 75 cases, and good proficiency
with the technique is usually associated with a low 1% to
2% conversion rate.20,21
Where senior surgeons are experienced with the tech-
nique, OPCAB can be safely and reproducibly taught to952 The Journal of Thoracic and Cardiovascular Surgtrainees.17,18,21 Careful early case selection with later
progression to more complex procedures under the tutelage
of experienced trainers has been shown to permit effective
training without increased morbidity, even among high-
risk patients.17,22 OPCAB has been an integral part of
our unit training program since the early days, with the
proportion of OPCAB procedures performed by trainees
increasing from 18% to 62% between the years 1999 to
2001.17,18 By the end of their 3rd year, residents have
performed 40 to 50 multivessel OPCAB revascularizations
as first surgeons under direct senior surgeon supervision.
An early comparison of outcomes demonstrated no
difference between patients operated on by senior surgeons
or supervised trainees.17 During the last 2 years of the train-
ing program, and after satisfying the senior surgeons
that they are proficient in OPCAB techniques, residents
are then permitted to perform OPCAB cases without direct
supervision. When the results of these unsupervised
cases were reviewed, again there was no increase in patient
morbidity relative to trainees operating under direct
supervision.17
A major criticism of the ROOBY trial was that 55%
of OPCAB cases were performed primarily by residents.9
Evidence seems strongly to suggest, however, that it is not
the residents but instead the lack of experienced trainers
that resulted in poor outcomes.
WHAT GROUP OF PATIENTS WILL BENEFIT
MOST FROM OPCAB?
To date, all prospective randomized trials evaluating
OPCAB have focused on low-risk patients or a mixed group
of patients, demonstratingOPCAB to be as effective and safe
as ONCAB. Observational studies, however, suggest that the
greatest benefits of OPCAB, in terms of reductions inmortal-
ity andmorbidity, may be seen among high-risk patients.23,24
These include women in general and patients with
a EuroSCORE greater than 5, left ventricle dysfunction,
atherosclerotic aortic disease, age older than 75 years,
diabetes, renal failure, left main stem disease, reoperations,
chronic lung disease, emergency coronary artery bypass
grafting, acute myocardial infarction, and preoperative
cerebrovascular disease (see online bibliography).
Currently, there are no published prospective randomized
comparisons of OPCAB versus ONCAB for the treatment
of high-risk patients. The recently published Best Bypass
Surgery Trial claimed to evaluate 30-day outcomes in 341
high-risk patients randomly allocated to undergo either OP-
CAB or ONCAB.25 The investigators reported no significant
difference in their composite primary outcome of adverse
cardiac and cerebrovascular events. This trial, however, did
not truly recruit high-risk patients. The exclusion criteria
were previous heart surgery, left ventricular ejection fraction
less than 30%, unstable preoperative condition, and emer-
gency surgery. There are currently 2 prospective randomizedery c November 2010
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risk patients. The CRISP trial run by our and the Oxford
unit (ISRCTN 29161170) is an international multicenter trial
randomly assigningmore than 5000 high-risk patients to OP-
CAB or ONCAB. The inclusion criterion is a EuroSCORE
greater than 5. The design of this trial is ‘‘expertise based,’’
with patients randomly allocated to previously specified sur-
geons in the same unit who favor and practice primarily OP-
CAB or ONCAB. The other is the German Off Pump
Coronary Artery Bypass in Elderly Study (GOPCABE,
NCT00719667), a multicenter trial randomly allocating
2000 patients older than 75 years (but excluding patients un-
dergoing reoperative surgery) to undergo either OPCAB or
ONCAB.CONCLUSIONS
An overwhelming wealth of evidence demonstrates that
OPCAB is a safe alternative to ONCAB, with similar out-
comes for low risk patients, and that it can be safely incorpo-
rated into routine surgical practice. It is an obviously
technically demanding procedure that should be performed
in high-volume OPCAB centers to obtain proficiency and
optimal outcomes. The greatest benefit of OPCAB is likely
to be seen in high risk patients, and the results of ongoing
prospective clinical trials are eagerly awaited.
The future of OPCAB remains bright and expansive.
OPCAB is a technique for the many and not the few, both
surgeons and patients, but only with structured training
and supervision in the right environment.References
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